Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Recruitment Status: Completed"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&lookfor=%22Humans%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&lookfor=%22Humans%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&lookfor=%22Humans%22&type=Subject
PubPharm (3.516)
1
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines : Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults : A Phase 1 Randomized, Observer-blind, Dose-escalation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an mRNA-based Monovalent Influenza Vaccine Candidate in Healthy Younger and Older Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older : Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults : A Phase 2, Randomized, Stratified, Observer-Blind Clinical Study to Evaluate Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine in Older Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea. : Assessment of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information in Korea.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children : Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children: FluSHED-2 Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older : Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adults Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers : Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age : A Phase 2b, Randomized, Observer-Blind, Antigen and Adjuvant Dose-Confirmation Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults ≥50 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older : A PHASE 3, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[352]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Completed
Medienart
3.516
Aufsätze
3.516
E-Artikel
3.516
E-Ressourcen
Zeitschriftentitel
2.366
ClinicalTrials.gov
1.150
WHO International Clinical Trials Registry Plat...
Thema
3.516
610
Recruitment Status: Completed
3.001
Study Type: Interventional
1.547
Influenza, Human
673
Medical Condition: Influenza
486
Phase: Phase 3
484
Study Type: Observational
460
Phase: Phase 1
414
HIV Infections
410
Phase: Phase 2
409
Acquired Immunodeficiency Syndrome
336
Phase: Phase 4
136
Immunologic Deficiency Syndromes
129
Infection
124
Communicable Diseases
93
Influenza in Birds
93
Medical Condition: Human Immunodeficiency Virus
91
Phase: Phase 1/Phase 2
85
Virus Diseases
75
Medical Condition: Influenza, Human
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.428
2020-
2.007
2010-2019
81
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.508
Englisch
6
Unbestimmt
2
Spanisch
Haven't found what you're looking for?
Wird geladen...